Immunovia publishes data sets on the Optimization Study and Commercial Test Model Study
LUND, SWEDEN – Immunovia AB (publ) (”Immunovia”) today published two new data sets in scientific poster formats, including results from the development phase of the Company’s IMMray™ PanCan-d blood based test for early detection of pancreatic cancer. The posters present the scientific data from the Optimization Study and the Commercial Test Model Study (CTMS) and demonstrate test performance for the different clinical indications. The posters can be found following this link to the company’s home page: https://immunovia.com/media/publications/immray-pancan-d/ For more information, please